Tom Gorman discusses and analyzes key issues and emerging trends in private securities actions following the Supreme Court decisions in Stoneridge (secondary liability); Tellabs (pleading scienter) and Dura Pharmaceuticals (loss causation), as well as other current key issues, including the use of confidential informants. In the latest installment of his popular series, our presenter covers such recent cases as Tellabs, on remand in the Seventh Circuit, as well as others throughout the country.